Health Canada Proposes Major Regulatory Overhaul To Combat Drug, Device Shortages
Compliance With New Provisions To Cost Industry CAD115m Over 10 Years
Canada’s health products regulator is inviting feedback on a range of new and revised guidelines and regulatory tools that explain how drug and device companies will be able to comply with significant changes proposed to its shortages framework.
